Trevor Gibbs has extensive International Development Experience in large Pharma, ranging from First-time-in-human to In-Market management). He led the GSK Clinical Safety & Pharmacovigilance function since 2001 and Medical Governance since 2004. 

He specialises in:

• Risk Assessment & Management of Development & Marketed assets both internal and external to the company.

• Risk Assessment & Management of key Medical Processes – especially those that are regulated or that have significant impact on company image

• Benefit / Harm Assessments of assets to inform both portfolio & market access decision-making
  Innovative solutions that transform business process

Trevor has held Board positions at the Edward Jenner Institute for Vaccine Research, was a Corporate Industrial Advisor to School of Health and Related Research (ScHARR), University of Sheffield, and served on the NICE Appraisals Committee for the 7 years following its inception. 

In 2009 Trevor joined ii4sm (international Institute for the Safety of Medicines), a systems and services provider, as Executive Vice President & Chief Medical Officer (www.ii4sm.com).

Trevor received his medical degree from Kings College Hospital School of Medicine, is a Fellow of the Royal College of Physicians and has recently been appointed as a Professor at the University of London’s School of Hygiene & Tropical Medicine.

Back to Associated Experts